(Q46239085)

20 December 2017

title

Analysis of factors affecting increase in bone mineral density at lumbar spine by bisphosphonate treatment in postmenopausal osteoporosis (English)

1 reference

20 December 2017

0 references

Hiroshi Kaji

1

1 reference

20 December 2017

Itoko Hisa

2

1 reference

20 December 2017

Yoshifumi Inoue

3

1 reference

20 December 2017

Junko Naito

4

1 reference

20 December 2017

Toshitsugu Sugimoto

5

1 reference

20 December 2017

Masato Kasuga

6

1 reference

20 December 2017

publication date

19 November 2008

1 reference

20 December 2017

Journal of Bone and Mineral Metabolism

published in

1 reference

20 December 2017

volume

27

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

76-82

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s00774-008-0005-y

exact match

0 references

cites work

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

1 reference

12 December 2020

Bone mineral density in adults with the metabolic syndrome: analysis in a population-based U.S. sample

1 reference

12 December 2020

Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents

1 reference

12 December 2020

Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women

1 reference

12 December 2020

Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial

1 reference

12 December 2020

Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women

1 reference

12 December 2020

Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture

1 reference

12 December 2020

Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women

1 reference

12 December 2020

Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures

1 reference

12 December 2020

Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study

1 reference

12 December 2020

Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

1 reference

12 December 2020

Alendronate for osteoporosis in men with androgen-repleted hypogonadism

1 reference

12 December 2020

Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study

1 reference

12 December 2020

Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation

1 reference

12 December 2020

Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial

1 reference

12 December 2020

Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition

1 reference

12 December 2020

Localization of regional forearm bone loss from high resolution computed tomographic images

1 reference

12 December 2020

Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study

1 reference

12 December 2020

Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study.

1 reference

12 December 2020

Risk of Fracture in Women with Type 2 Diabetes: the Women’s Health Initiative Observational Study

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk

1 reference

12 December 2020

Osteoporosis in patients with diabetes mellitus.

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women

1 reference

12 December 2020

Vitamin D status and redefining serum parathyroid hormone reference range in the elderly

1 reference

12 December 2020

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis

1 reference

12 December 2020

Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells

1 reference

12 December 2020

Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects.

1 reference

12 December 2020

Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women

1 reference

12 December 2020

10.1007/S00774-008-0005-Y

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19018454

1 reference

20 December 2017